Researchers found that patients who achieved the greatest reductions in body weight after starting GLP-1-based medications had substantially lower risks of conditions including obstructive sleep apnea, chronic kidney disease, osteoarthritis, and heart failure
Probiotic-rich foods or supplements have low risk and some people report benefit, though the evidence specifically for GLP-1-related diarrhea is limited
Notably, Kaileras stance on injectables vs orals is that both are needed: CEO Renaud has stated, We do not believe that injectables are things of the pastGLP-1 injectable approaches are foundational for treating patients who need greater weight loss ( [46] )
Related products -3%Out of stockRead moreQuick ViewInjectable Products Ignis Primo 150 5.00 out of 5 65.00 Original price was: 65.00.62.99Current price is: 62.99
The medication has demonstrated remarkable effectiveness, helping patients achieve sustainable weight loss and improved glycemic control